Rapid Screening of MCM Efficacy Against SARS-CoV-2 Pseudoviruses with Spike Variants
Overview
- Response deadline
- 3:00 PM UTC−04:00
- Posted
- April 28, 2021
- Notice type
- Combined Synopsis/Solicitation
- NAICS
- 621511: Medical Laboratories
- Agency
- Department of Health and Human ServicesOFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE
Notice details
- Office
- ASPR BARDA DIV CONTRACTS MGMT & ACQ
- Last updated
- Sep 25, 2026
Identifiers
- Solicitation number
- 75A50121R00033
- Notice ID
- eab11587a2b0485e861783f7ddfc754b
Description
This is a re-issuance of a solicitation. The small business set-aside is disolved in accordance with FAR 19.502-10 Automatic dissolution of a small business set-aside. See attached CSS with Attachments.
Award Overview
No prior contract identified
No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.
Contacts
Contracting Officer
Primary Contact
Documents
No documents available.
Lifecycle
Solicitation:
75A50121R00033- Combined Synopsis
- 2×Combined SynopsisCurrentApr 6, 2021
Rapid Screening of MCM Efficacy Against SARS-CoV-2 Pseudoviruses with Spike Variants
Similar Opportunities
Title | Match | Phase | Deadline |
|---|---|---|---|
Additional Details
Solicitation Number
75A50121R00033
Archive Date
May 22, 2021
Office Address
Washington, DC, 20515